Summary
In recent years a growing number of inherited diseases in man have been recognized in which there is an impairment in peroxisomal β-oxidation. In some diseases this is due to the (virtual) absence of peroxisomes leading to a generalized loss of peroxisomal functions including peroxisomal β-oxidation. In most inborn errors of peroxisomal β-oxidation, however, peroxisomes are normally present and the impairment in peroxisomal β-oxidation is due to the single or multiple loss of peroxisomal β-oxidation enzyme activities. In all these disorders there is accumulation of very-long-chain fatty acids in plasma, which allows biochemical diagnosis of patients affected by an inborn error of peroxisomal β-oxidation to be done via gas-chromatographic analysis of plasma very-long-chain fatty acids. Subsequent enzymic and immunological investigations are required to identify the precise enzymic defects in these patients. In all inborn errors of peroxisomal β-oxidation known today there are multiple abnormalities, especially neurological with death usually occurring in the first decade of life. Prenatal diagnosis of these disorders has recently become possible.
Similar content being viewed by others
References
Aubourg, P., Bougneres, P. F. and Rocchiccioli, F. Capillary gas-liquid chromatographic-mass spectrometric measurement of very long chain (C22 to C26) fatty acids in microliter samples of plasma.J. Lipid. Res. 26 (1985) 263–267
Bakkeren, J. A. J. M., Monnens, L. A. H., Trijbels, J. M. F. and Maas, J. M. Serum very long chain fatty acid pattern in Zellweger syndrome.Clin. Chim. Acta 138 (1984) 325–331
Bhusnan, A., Singh, R. P. and Singh, I. Characterization of rat brain microsomal acylcoenzyme A ligase: different enzymes for the synthesis of palmitoyl-CoA and lignoceroyl-CoA.Arch. Biochem. Biophys. 246 (1986) 374–380
Björkhem, I., Kase, B. F. and Pedersen, J. I. Role of peroxisomes in the biosynthesis of bile acids.Scand. J. Clin. Lab. Invest. 45 Suppl. 177 (1985) 23–31
Boué, J., Oberle, I., Heilig, R., Mandel, J. L., Moser, A., Moser, H., Larsen, J. W., Dumez, Y. and Boué, A. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe.Hum. Genet. 69 (1985) 272–274
Bremer, J. Carnitine and its role in fatty acid metabolism.Trends Biochem. Sci. 2 (1977) 207–209
Bremer, J. and Osmundsen, H. Fatty acid oxidation and its regulation. In Numa, S. (ed.)Fatty Acid Metabolism and its Regulation, Elsevier, Amsterdam, 1984, pp. 113–154
Bremer, J. and Norum, K. R. Metabolism of very long chain monounsaturated fatty acids (C22: 1) and the adaptation to their presence in the diet.J. Lipid. Res. 23 (1982) 243–256
Casteels, M., Schepers, L., Van Eldere, J., Eyssen, H. and Mannaerts, G. P. Inhibition of 3α, 7α, 12α-trihydroxy-5β-cholestanoic acid oxidation and of bile acid secretion in rat liver by fatty acids.J. Biol. Chem. 263 (1988) 4654–4661
Chen, W. W., Watkins, P. P., Osumi, T., Hashimoto, T. and Moser, H. W. Peroxisomal β-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked and neonatal adrenoleukodystrophy.Proc. Natl. Acad. Sci. USA 84 (1987) 1425–1428
Christensen, E., Hagve, T-A. and Christopherson, B. O. The Zellweger syndrome: deficient chain-shortening of erucic acid (22: 1 (n-9)) and adrenic acid (22: 4 (n-6)) in cultured skin fibroblasts.Biochem. Biophys. Acta 959 (1988) 95–99
Christiansen, R. Z. The effect of clofibrate feeding on hepatic fatty acid metabolism.Biochim. Biophys. Acta 530 (1978) 314–324
Clayton, P. T., Lake, B. D., Hall, N. A., Shortland, D. B., Carruthers, R. A. and Lawson, A. M. Plasma bile acids in patients with peroxisomal dysfunction syndromes: analysis by capillary gas chromatography-mass spectrometry.Eur. J. Pediatr. 146 (1987) 166–173
Clayton, P. T., Lake, B. D., Hjelm, M., Stephenson, J. B., Besley, G. T. N., Wanders, R. J. A., Schram, A. W., Tager, J. M., Schutgens, R. B. H. and Lawson, A. M. Bile acid analyses in ‘pseudo-Zellweger’ syndrome: clues to the defect in peroxisomal β-oxidation.J. Inher. Metab. Dis. 11 Suppl. 2 (1988) 165–168
Cooper, T. G. and Beevers, H. β-oxidation in glyoxysomes from castor bean endosperm.J. Biol. Chem. 244 (1969) 3514–3520
Diczfalusy, U. and Alexson, S. E. H. Peroxisomal chain-shortening of prostaglandine F2α.J. Lipid Res. 29 (1988) 1629–1636
Diczfalusy, U., Alexson, S. E. H. and Pedersen, J. I. Chain-shortening of prostaglandin F2α by rat liver peroxisomes.Biochem. Biophys. Res. Commun. 144 (1987) 1206–1215
Dommes, V., Baumgart, C. and Kunau, W. H. Degradation of unsaturated fatty acids in peroxisomes.J. Biol. Chem. 256 (1981) 8259–8262
Dommes, V. and Kunau, W. H. Purification and properties of acyl coenzyme A dehydrogenases from bovine liver.J. Biol. Chem. 259 (1984) 1781–1788
Farrell, S. O. and Bieber, L. L. Carnitine octanoyltransferase of mouse liver peroxisomes: properties and effect of hypolipidemic drugs.Arch. Biochem. Biophys. 222 (1983) 123–132
Furuta, S., Miyazawa, S., Osumi, T., Hashimoto, T. and Ui, N. Properties of mitochondrial and peroxisomal enoyl-CoA hydratase from rat liver.J. Biochem. 88 (1980) 1059–1070
Furuta, S., Miyazawa, S. and Hashimoto, T. Purification and properties of rat liver acyl-CoA dehydrogenases and electron transfer flavoprotein.J. Biochem. 90 (1981) 1739–1750
Goldfischer, S., Collins, J., Rapin, I., Coltoff-Schiller, B., Chang, C. H., Nigro, M., Black, V. H., Javitt, N. B., Moser, H. W. and Lazarow, P. B. Peroxisomal defects in neonatal and X-linked adrenoleukodystrophy.Science 227 (1985) 67–70
Goldfischer, S., Collins, H., Rapin, I., Neumann, P., Neglia, W., Spiro, A. J., Ishii, T., Roels, F., Vamecq, J. and van Hoof, F. Pseudo-Zellweger syndrome: deficiences in several peroxisomal oxidative activities.J. Pediatr. 108 (1986) 25–32
Hall, N. A., Lynes, G. W. and Hjelm, N. H. Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.Clin. Chem. 34 (1988) 1041–1045
Hamberg, M. Metabolism of prostaglandins in rat liver mitochondria.Eur. J. Biochem. 6 (1968) 135–146
Hashmi, M., Stanley, W. and Singh, I. Lignoceroyl-CoASH ligase: enzyme defect in fatty acid β-oxidation systems in X-linked childhood adrenoleukodystrophy.FEBS Lett. 196 (1986) 347–350
Hiltunen, J. K., Kärki, T., Hassinen, I. E. and Osmundsen, H. β-oxidation of polyunsaturated fatty acids by rat liver peroxisomes. A role for 2, 4-dienoyl-coenzyme A reductase in peroxisomal β-oxidation.J. Biol. Chem. 261 (1986) 16484–16493
Hovik, R. and Osmundsen, H. Peroxisomal β-oxidation of long-chain fatty acids processing different extents of unsaturation.Biochem. J. 247 (1987) 531–535
Inestrosa, N. C., Bronfman, M. and Leighton, F. Detection of peroxisomal fatty acyl-coenzyme A oxidase activity.Biochem. J. 182 (1979) 779–788
Inestrosa, N. C., Bronfman, M. and Leighton, M. Purification of the peroxisomal fatty acyl-CoA oxidase from rat liver.Biochem. Biophys. Res. Commun. 95 (1980) 7–12
Janssen, G., Toppet, S. and Parmentier, G. Structure of the side chain of the C29 dicarboxylic bile acid occurring in infants with coprostanic acidemia.J. Lipid Res. 23 (1982) 456–463
Kärki, T., Hakkola, E., Hassinen, I. E. and Hiltunen, J. K. β-oxidation of polyunsaturated fatty acids in peroxisomes. Subcellular distribution of Δ3, Δ2-enoyl-CoA isomerase activity in rat liver.FEBS Lett. 215 (1987) 228–232
Kase, B. F., Björkhem, I. and Pedersen, J. I. Formation of cholic acid from 3α, 7α, 12α-trihydroxy-5β-cholestanoic by rat liver peroxisomes.J. Lipid Res. 24 (1983) 1560–1567
Kase, B. F., Pedersen, J. I., Strandvick, B. and Björkhem, I.In vivo andin vitro studies on the formation of bile acids in patients with the Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic acid and chenodeoxycholic acid.J. Clin. Invest. 76 (1985a) 2393–2402
Kase, B. F., Björkhem, I., Haga, P. and Pedersen, J. I. Defective peroxisomal cleavage of the C27-steroid side chain in the cerebro-hepato-renal syndrome of Zellweger.J. Clin. Invest. 75 (1985b) 427–435
Kase, B. F., Prydz, K., Björkhem, I. and Pedersen, J. I.In vitro formation of bile acids from di- and trihydroxy-5β-cholestanoic acid in human liver peroxisomes.Biochim. Biophys. Acta 877 (1986) 37–42
Kawamura, N., Moser, H. W. and Kishimoto, Y. Very long chain fatty acid oxidation in rat liver.Biochem. Biophys. Res. Commun. 99 (1981) 1216–1225
Kimura, C., Kondo, A., Koeda, N., Yamanaka, H. and Mizugaki, M. Studies on the metabolism of unsaturated fatty acids. XV. Purification and properties of 2, 4-dienoyl-CoA reductase from rat liver peroxisomes.J. Biochem. 96 (1984) 1463–1469
Knazek, R. A., Rizzo, W. B., Schulman, J. D. and Dave, J. R. Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy.J. Clin. Invest. 72 (1983) 245–248
Kolvraa, S. and Gregersen, N.In vitro studies on the oxidation of medium chain dicarboxylic acids in rat liver.Biochim. Biophys. Acta 876 (1986) 515–525
Krisans, S. K., Mortensen, R. M. and Lazarow, P. B. Acyl-CoA synthetase in rat liver peroxisomes.J. Biol. Chem. 255 (1980) 9599–9607
Kunau, W. H. and Schulz, H. β-oxidation of unsaturated fatty acids: a revised pathway.Trends Biochem. Sci. 12 (1987) 403–406
Kunau, W. H., Kionka, C., Ledebur, A., Mateblowski, M., Moreno de la Garza, M., Schultz-Borchard, U., Thieringer, R. and Veenhuis, M. β-oxidation systems in eukaryotic microorganisms. In Fahimi, H. D. and Sies, H. (eds.)Peroxisomes in Biology and Medicine, Springer-Verlag, Berlin, Heidelberg, 1987, pp. 128–140
Lazarow, P. and de Duve, C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes: enhancement by clofibrate, a hypolipidemic drug.Proc. Natl. Acad. Sci. USA 73 (1976) 2043–2046
Lazarow, P. B., Black, V., Shio, H., Fujiki, Y., Hajra, A. K., Datta, N. S., Bangaru, B. S. and Dancis, J. Zellweger syndrome: biochemical and morphological studies on two patients treated with clofibrate.Pediatr. Res. 19 (1985) 1356–1364
Lazarow, P. B. and Moser, H. W. Disorders of peroxisome biogenesis. In Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.)The Metabolic Basis of Inherited Disorders, McGraw-Hill, New York, 1989, in press
Lazo, O., Contreras, M., Hashmi, M., Stanley, W., Irazu, C. and Singh, I. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.Proc. Natl. Acad. Sci. USA 85 (1988) 7647–7651
Mannaerts, G. P., Van Veldhoven, P., Van Broekhoven, A., Van de Broek, G. and De Beer, L. J. Evidence that peroxisomal acyl-CoA synthetase is located at the cytoplasmic site of the peroxisomal membrane.Biochem. J. 204 (1982) 17–23
Markwell, M. A. K., McGroarty, E. J., Bieber, L. L. and Tolbert, N. E. The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme.J. Biol. Chem. 248 (1973) 3426–3452
Markwell, M. A. K., Tolbert, N. E. and Bieber, L. L. Comparison of the carnitine acyltransferase activities from rat liver peroxisomes and microsomes.Arch. Biochem. Biophys. 176 (1976) 479–488
Masui, T. and Staple, E. The formation of bile acids from cholesterol.J. Biol. Chem. 241 (1966) 3889–3893
Meyer, W. J., Smith, E. M., Richards, G. E., Greger, N. G., Brosnan, P. G. and Keenan, B. S. ACTH receptor defect in adrenoleukodystrophy.Pediatr. Res. 21 (1987) 465A (abstr.)
Middleton, B. The oxoacyl CoA thiolases of animal tissues.Biochem. J. 132 (1973) 717–730
Miyazawa, S., Osumi, T. and Hashimoto, T. The presence of a new 3-oxoacyl-CoA thiolase in rat liver peroxisomes.Eur. J. Biochem. 103 (1980) 589–596
Miyazawa, S., Furuta, S., Osumi, T., Hashimoto, T. and Ui, N. Properties of peroxisomal 3-ketoacyl-CoA thiolase from rat liver.J. Biochem. 90 (1981) 511–519
Miyazawa, S., Ozasa, H., Furuta, S., Osumi, T. and Hashimoto, T. Purification and properties of carnitine acetyltransferase from rat liver.J. Biochem. 93 (1983a) 439–451
Miyazawa, S., Ozasu, H., Osumi, T. and Hashimoto, T. Purification and properties of carnitine octanoyltransferase and carnitine palmitoyltransferase from rat liver.J. Biochem. 94 (1983b) 529–542
Miyazawa, S., Hashimoto, T. and Yokota, S. Identity of long-chain acyl coenzyme A synthetase of microsomes, mitochondria and peroxisomes in rat liver.J. Biochem. 98 (1985) 723–733
Molzer, B., Bernheimer, H., Heller, R., Toifl, K. and Vetterlein, M. Detection of adrenoleukodystrophy by increased C26: 0 fatty acid levels in leukocytes.Clin. Chim. Acta 125 (1982) 299–305
Molzer, B., Korchinksy, M., Bernheimer, H., Schmid, R., Wolf, R. and Roscher, A. Very long chain fatty acids in genetic peroxisomal disease fibroblasts: differences between the cerebrohepato-renal (Zellweger) syndrome and adrenoleukodystrophy variants.Clin. Chim. Acta 161 (1986) 81–90
Moser, A. E., Borel, J., Odone, A., Naidu, S., Cornblath, D., Sanders, D. B. and Moser, H. W. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.Ann. Neurol. 21 (1987) 240–249
Moser, H. W., Moser, A. B., Kawamura, N., Murphy, J., Suzuki, K., Schaumburg, H. H., Kishimoto, Y. and Milunsky, A. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.Ann. Neurol. 7 (1980) 542–549
Moser, H. W., Naidu, S., Kumar, A. J. and Rosenbaum, A. E. The adrenoleukodystrophies.CRC Crit. Rev. Neurobiol. 3 (1987) 29–88
Naidu, S., Hoefler, G., Watkins, P. A., Chen, W. W., Moser, A. B., Hoefler, S., Rance, N. E., Powers, J. M., Beard, M., Green, W. R., Hashimoto, T. and Moser, H. W. Neonatal seizures and retardation in a girl with biochemical features of X-linked adrenoleukodystrophy.Neurology 38 (1988) 1100–1107
Osumi, T. and Hashimoto, T. Acyl-CoA oxidase of rat liver: a new enzyme for fatty acid oxidation.Biochem. Biophys. Res. Commun. 83 (1978) 479–485
Osumi, T. and Hashimoto, T. Peroxisomal β-oxidation system of rat liver. Copurification of enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase.Biochem. Biophys. Res. Commun. 89 (1979) 580–584
Osumi, T. and Hashimoto, T. Purification and properties of mitochondrial and peroxisomal 3-hydroxyl-acyl-CoA dehydrogenase from rat liver.Arch. Biochem. Biophys. 203 (1980a) 372–383
Osumi, T., Hashimoto, T. and Ui, N. Acyl-CoA oxidase of rat liver: a new enzyme for fatty acid oxidation.J. Biochem. 87 (1980b) 1735–1746
Palosaari, P. M., Autio-Harmainen, H., Sormunen, R., Hassinen, I. E. and Hiltunen, J. K. β-oxidation of polyunsaturated fatty acids. Peroxisomal Δ3-Δ2-enoyl-CoA isomerase in rat liver.International Union of Biochemistry Congress, 1988 (Abstr.)
Pampols, T., Ribes, A., Pineda, M., Ballester, A., Fernandez-Alvarez, E., Moser, A. E. and Moser, H. W. Medium chain dicarboxylic and hydroxydicarboxylic aciduria in a case of neonatal adrenoleukodystrophy.J. Inher. Metab. Dis. 10 (Suppl. 2) (1987) 217–219
Parmentier, G. G., Janssen, G. A., Eggermont, E. A. and Eyssen, H. J. C27-bile acids in infants with coprostanic acidemia and occurrence of a 3α, 7α, 12α-trihydroxy-5β-C29-dicarboxylic acid as a major component in their serum.Eur. J. Biochem. 102 (1979) 173–183
Paturneau-Jouas, M., Taillard, F., Gansmuller, A., Schutgens, R., Mikol, J., Aigrot, M. S. and Sereni, C. Clinical, biochemical, pathological ‘Zellweger-like’ disorder with morphological normal peroxisomes. In Salvayre, R., Douste-Blazy, L. and Gatt, S. (eds.)Lipid Storage Disorders: Biological and Medical Aspects, NATO ASI series, Life Sciences Vol. 150, 1988, pp. 805–809
Pedersen, J. I. and Gustafsson, J. Conversion of 3α, 7α, 12α-trihydroxy-5β-cholestanoic acid into cholic acid by rat liver peroxisomes.FEBS Lett. 121 (1980) 345–348
Pederson, J. I., Hvattum, E., Flatabo, T. and Björkhem, I. Clofibrate does not induce peroxisomal 3α, 7α, 12α-trihydroxy-5β-cholestanoyl coenzyme A oxidation in rat liver: evidence that this reaction is catalyzed by an enzyme system different from that of peroxisomal acyl-CoA oxidation.Biochem. Int. 17 (1988) 163–169
Poll-Thé, B. T., Saudubray, J. M., Ogier, H. A. M., Odièvre, M., Scotto, M., Monnens, L., Govaerts, L. C. P., Roels, F., Cornelis, A., Schutgens, R. B. H., Wanders, R. J. A., Schram, A. W. and Tager, J. M. Infantile Refsum disease: an inherited peroxisomal disorder; comparison with Zellweger syndrome and neonatal adrenoleukodystrophy.Eur. J. Pediatr. 146 (1987) 477–483
Poll-Thé, B. T., Roels, F., Ogier, H., Scotto, J., Vamecq, J., Schutgens, R. B. H., Wanders, R. J. A., van Roermund, C. W. T., van Wijland, M. J. A., Schram, A. W., Tager, J. M. and Saudubray, J. M. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudoneonatal adrenoleukodystrophy).Am. J. Hum. Genet. 42 (1988) 422–434
Poulos, A., Singh, H., Paton, B., Sharp, P. and Derwas, N. Accumulation and defective gb-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.Clin. Genet. 29 (1986) 397–408
Poulos, A., Sharp, P., Fellenberg, A. J., and Johnson, D. W. Accumulation of pristanic acid in the plasma of patients with generalised peroxisomal dysfunction.Eur. J. Pediatr. 147 (1988) 143–147
Powers, J. M. Adreno-leukodystrophy.Clin. Neuropath. 4 (1985) 191–199
Prydz, K., Kase, B. F., Björkhem, I. and Pedersen, J. I. Subcellular localization of 3α, 7α-dihydroxy- and 3α, 7α, 12α-trihydroxy-5β-cholestanoyl-coenzyme A ligase(s) in rat liver.J. Lipid. Res. 29 (1988) 997–1004
Rizzo, W. B., Phillips, M. W., Damman, A. L., Leshner, R. T., Jennings, S. S., Avigan, J. and Proud, V. K. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.Ann. Neurol. 21 (1987) 232–239
Rocchiccioli, F., Aubourg, P. and Bougneres, F. Medium and long-chain dicarboxylic aciduria in patients with Zellweger syndrome and neonatal adrenoleukodystrophy.Pediatr. Res. 20 (1986) 62–66
Rocchiccioli, F., Aubourg, P. and Choiset, A. Immediate prenatal diagnosis of Zellweger syndrome by direct measurement of very long chain fatty acids in chorionic villus cells.Prenat. Diagn. 7 (1987) 349–354
Schepers, L., Casteels, M., Vamecq, J., Parmentier, G., Van Veldhoven, P. P. and Mannaerts, G. P. β-oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria.J. Biol. Chem. 263 (1988) 2724–2731
Schepers, L., Casteels, M., Verheyden, K., Parmentier, G., Asselberghs, S., Eyssen, H. J. and Mannaerts, G. P. Subcellular distribution and characteristics of trihydroxycoprostanoyl-CoA synthetase.Biochem. J. 257 (1989) 221–229
Schram, A. W., Strijland, A., Hashimoto, T., Wanders, R. J. A., Schutgens, R. B. H., van den Bosch, H. and Tager, J. M. Biosynthesis and maturation of peroxisomal β-oxidation enzymes in fibroblasts in relation to the Zellweger syndrome and infantile Refsum disease.Proc. Natl. Acad. Sci. USA 83 (1986) 6156–6158
Schram, A. W., Goldfischer, S., van Roermund, C. W. T., Brouwer-Kelder, E. M., Collins, J., Hashimoto, T., Heymans, H. S. A., van den Bosch, H., Schutgens, R. B. H., Tager, J. M. and Wanders, R. J. A. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency.Proc. Natl. Acad. Sci. USA 84 (1987) 2494–2497
Schulz, H. Oxidation of fatty acids. In Vance, D. E. and Vance, F. E. (eds.)Biochemistry of Lipids and Membranes, Benjamin/Cummings, Menlo Park, CA, 1985, pp. 116–142
Schutgens, R. B. H., Heymans, H. S. A., Wanders, R. J. A., van den Bosch, H. and Tager, J. M. Peroxisomal disorders: a newly recognized group of genetic diseases.Eur. J. Pediatr. 144 (1986) 430–440
Schutgens, R. B. H., Schrakamp, G., Wanders, R. J. A., Heymans, H. S. A., Tager, J. M. and van den Bosch, H. Pre- and perinatal diagnosis of peroxisomal disorders.J. Inher. Metab. Dis. 12 Suppl. 1 (1989) 118–134
Shimozowa, N., Suzuki, Y., Orii, T. and Hashimoto, T. Immunoblot detection of enzyme proteins of peroxisomal β-oxidation in fibroblasts, amniocytes and chorionic villous cells.Prenat. Diagn. 8 (1988) 287–298
Shindo, Y. and Hashimoto, T. Acyl-coenzyme A synthetase and fatty acid oxidation in rat liver peroxisomes.J. Biochem. 84 (1978) 1177–1181
Singh, I. and Kishimoto, Y. Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside and on the enzymatic reactions involving these compounds.J. Lipid Res. 24 (1983) 662–665
Singh, I., Moser, A. B., Goldfischer, S. and Moser, H. W. Lignoceric acid is oxidized in the peroxisomes; implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.Proc. Natl. Acad. Sci. USA 81 (1984) 4203–4207
Singh, H. and Poulos, A. A comparative study of stearic acid and lignoceric acid oxidation by human skin fibroblasts.Arch. Biochem. Biophys. 250 (1986) 171–179
Singh, H., Derwas, N. and Poulos, A. β-Oxidation of very long chain fatty acids and their coenzyme A derivatives by human skin fibroblasts.Arch. Biochem. Biophys. 254 (1987a) 526–533
Singh, H., Derwas, N. and Poulos, A. Very long chain fatty acid β-oxidation by rat liver mitochondria and peroxisomes.Arch. Biochem. Biophys. 359 (1987b) 382–390
Staack, H., Binstock, J. F. and Schulz, H. Purification and properties of a pig heart thiolase with broad chain length specificity and comparison of thiolases from heart andEscherichia coli.J. Biol. Chem. 253 (1978) 1827–1831
Steinberg, D. Phytanic acid storage disorders. In Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., Goldstein, J. L. and Brown, M. S. (eds.)The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1983, pp. 731–747
Stoffel, W. and Caesar, H. Der Stoffwechsel der ungesättigten Fettsäuren. V. Zur β-Oxidation der Mono- und Polyenfettsäuren. Der Mechanismus der enzymatischen Reaktionen an 3-cis-enoyl-CoA-Verbindungen.Hopple-Seyler's Z. Physiol. Chem. 341 (1965) 76–83
Stoffel, W., Ditzer, R. and Caesar, H. Der Stoffwechsel der ungesättigten Fettsäuren. III. Zur β-Oxidation der Mono- und Polyenfettsäuren. Der Mechanismus der enzymatischen Reaktionen an 3-cis-enoyl-CoA-Verbindungen.Hoppe-Seyler's Z. Physiol. Chem. 339 (1964) 167–181
Stokke, O., Jellum, E., Kvittingen, E. A., Skjeldal, O. and Hristendal, G. Epoxy acids in peroxisomal disorders.Scand. J. Clin. Lab. Invest. 46 (1986) 95–96
Suzuki, Y., Orii, T., Mori, M., Tatibana, M. and Hashimoto, T. Deficient activities and proteins of peroxisomal β-oxidation enzymes in infants with Zellweger syndrome.Clin. Chim. Acta 156 (1986) 191–196
Suzuki, Y., Shimozawa, N., Orii, T., Igarashi, N., Kono, N., Matsui, A., Inoue, Y., Yokota, S. and Hashimoto, T. Zellweger-like syndrome with detectable hepatic peroxisomes: a variant form of peroxisomal disorder.J. Pediatr. 113 (1988a) 841–845
Suzuki, Y., Shimozawa, N., Orii, T., Igarashi, N., Kono, N. and Hashimoto, T. Molecular analysis of peroxisomal β-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorders.Clin. Chim. Acta 172 (1988b) 65–76
Tager, J. M., Ten Harmsen van de Beek, W. A., Wanders, R. J. A., Hashimoto, T., Heymans, H. S. A., van den Bosch, H., Schutgens, R. B. H. and Schram, A. W. Peroxisomal β-oxidation enzyme proteins in the Zellweger syndrome.Biochem. Biophys. Res. Commun. 126 (1985) 1269–1275
Tanaka, T., Hosaka, T., Hoshimaru, M. and Numa, S. Purification and properties of long-chain acyl coenzyme A synthetase from rat liver.Eur. J. Biochem. 98 (1979) 165–172
Vamecq, J., de Hoffmann, E. and Van Hoof, F. The microsomal dicarboxylyl-CoA synthetase.Biochem. J. 230 (1985) 683–693
Vamecq, J. and Draye, J. P. Interaction between the ω- and β-oxidation of fatty acids.J. Biochem. 102 (1987) 225–234
Van Eldere, J. R., Parmentier, G. G., Eyssen, H. J., Wanders, R. J. A., Schutgens, R. B. H., Vamecq, J., Van Hoof, F., Poll-Thé, B. T. and Saudubray, J. M. Bile acids in peroxisomal disorders.Eur. J. Clin. Invest. 17 (1987) 386–390
Vianey-Liaud, C., Divry, P., Gregersen, N. and Mathieu, M. The inborn errors of mitochondrial fatty acid oxidation.J. Inher. Metab. Dis. 10 Suppl. 1 (1987) 159–198
Wanders, R. J. A., Schutgens, R. B. H., Schrakamp, G., van den Bosch, H., Tager, J. M., Schram, A. W., Hashimoto, T., Poll-Thé, B. T. and Saudubray, J. M. Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes), alkyldihydroxyacetone phosphate synthase and peroxisomal β-oxidation enzyme proteins.Eur. J. Pediatr. 145 (1986) 172–175
Wanders, R. J. A., van Roermund, C. W. T., van Wijland, M. J. A., Nijenhuis, A. A., Tromp, A., Schutgens, R. B H., Brouwer-Kelder, E. M., Schram, A. W., Tager, J. M., van den Bosch, H. and Schalkwijk, C. C. X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acid but not of very long chain fatty acyl-CoA esters.Clin. Chim. Acta 165 (1987a) 321–329
Wanders, R. J. A., van Roermund, C. W. T., van Wijland, M. J. A., Heikoop, J., Schutgens, R. B. H., Schram, A. W., van den Bosch, H., Poll-Thé, B. T., Saudubray, J. M., Moser, H. W. and Moser, A. B. Peroxisomal very long chain fatty acid β-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.Clin. Chim. Acta 166 (1987b) 255–263
Wanders, R. J. A., van Roermund, C. W. T., van Wijland, M. J. A., Schutgens, R. B. H., Heikoop, J., van den Bosch, H., Schram, A. W. and Tager, J. M. Peroxisomal fatty acid β-oxidation in relation to the accumulation of very long chain fatty acids in peroxisomal disorders.J. Clin. Invest. 80 (1987c) 1778–1783
Wanders, R. J. A., van Roermund, C. W. T., van Wijland, M. J. A., Schutgens, R. B. H., Schram, A. W., van den Bosch, H. and Tager, J. M. Studies on the peroxisomal oxidation of palmitate and lignocerate in rat liver.Biochim. Biophys. Acta 919 (1987d) 21–25
Wanders, R. J. A., Heymans, H. S. A., Schutgens, R. B. H., Barth, P. G., van den Bosch, H. and Tager, J. M. Peroxisomal disorders in neurology.J. Neurol. Sci. 88 (1988a) 1–39
Wanders, R. J. A., van Roermund, C. W. T., van Wijland, M. J. A., Schutgens, R. B. H., van den Bosch, H., Schram, A. W. and Tager, J. M. Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids.Biochem. Biophys. Res. Commun. 153 (1988b) 618–624
Wanders, R. J. A., van Roermund, C. W. T., van Wijland, M. J. A., Schutgens, R. B. H., van den Bosch, H., Schram, A. W. and Tager, J. M. Identification of the primary defect in X-linked adrenoleukodystrophy: oxidation of very long chain fatty acids is deficient due to an impaired ability of peroxisomes to activate very long chain fatty acids. In Salvayre, R., Douste-Blazy, M. L. and Gatt, S. (eds.)Lipid Storage Disorders: Biological and Medical Aspects, NATO ASI-series, Life Sciences Vol. 150, Plenum Press, New York and London, 1988c, pp. 405–412
Wanders, R. J. A., van Roermund, C. W. T., Schelen, A., Schutgens, R. B. H., van den Bosch, H. and Tager, J. M. X-linked adrenoleukodystrophy and other inborn errors of peroxisomal β-oxidation: identification of the primary defect using enzymic and immunological methods. In Tanaka, K. and Coates, P. M. (eds.)Clinical, Biochemical and Molecular Aspects of Fatty Acid Oxidation, Alan Liss, New York, 1989, in press
Watkins, P. A., Chen, W. W., Harris, C. J., Hoefler, G., Hoefler, S., Blake, D. C., Balfe, A., Kelley, R. I., Moser, A. B., Beard, M. E. and Moser, H. W. Peroxisomal bifunctional enzyme deficiency.J. Clin. Invest. 83 (1989) 771–777
Whitcomb, R. W., Linehan, W. M. and Knazek, R. A. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cellsin vitro.J. Clin. Invest. 81 (1988) 185–188
Yamada, J., Horie, S., Watanabe, T. and Suga, T. Participation of peroxisomal β-oxidation system in the chain-shortening of a xenobiotic acyl compound.Biochem. Biophys. Res. Commun. 125 (1984) 123–128
Yamada, J., Itoh, S., Horie, S., Watanabe, T. and Suga, T. Chain-shortening of a xenobiotic acyl compound by the peroxisomal β-oxidation system in rat liver.Biochem. Pharmac. 35 (1986) 4363–4368
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wanders, R.J.A., van Roermund, C.W.T., Schutgens, R.B.H. et al. The inborn errors of peroxisomal β-oxidation: A review. J Inherit Metab Dis 13, 4–36 (1990). https://doi.org/10.1007/BF01799330
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01799330